Clinical research is evolving—and so are the expectations for compliance. Beyond Clinical Compliance is a working conference for quality, operations, and compliance professionals who are ready to think differently about risk, oversight, and inspection readiness in the era of ICH E6(R3).
Session Topics Include:
CHAMPIONS OF QUALITY
They Built the Culture Behind Compliance: How Quality Leaders Create Environments Where the Right Decisions Actually Happen
RISK TRIAGE IN COMPLEX TRIALS
When Everything Looks Like Risk: How Clinical Quality Teams Can Triage Oversight in Complex Trials
SUPPLIER QUALIFICATION
Peeling Back the Layers: How Risk-Based Supplier Qualification is Changing Clinical Oversight
CROSS FUNCTIONAL OVERSIGHT
When Everyone Owns the Risk, No One Does: The Reality of Cross-Functional Oversight
AI AND INNOVATION RISKS
Leveraging Innovative Technologies to Drive Efficiency Without Creating New Compliance Risks
SCALING CLINICAL OVERSIGHT AND SUPPORT
Your Team Can’t Do Everything: How Leaders are Expanding Expertise Without Slowing Trials
AVOIDING THE INSPECTION SCRAMBLE
Stop Fixing Problems Right Before Submission: Building Inspection Readiness Earlier
GCP INSPECTION GOSSIP
What Teams Have Experienced During Recent Inspections—and How They Are Adapting in a Time of Change
INSIDE THE CLINICAL TRIAL
What the Patient Experience Reveals About Trust, Communication, and Trial Design
INTERACTIVE: OPERATIONALIZING RBQM
How Do YOU Decide What Actually Deserves Oversight?
BRIDGING THE OVERSIGHT GAP
When Oversight Breaks Down: Real Scenarios That Test Operational and Quality Alignment
Reetu Dandora, SVP, Quality & Regulatory Compliance, AVEO ONCOLOGY
Teresa DeVincentis, Quality Head, SOLID BIOSCIENCES
Donna Dorozinsky, Founder & CEO, JUST IN TIME GCP
Gaby Graterol, Associate Director, Clinical QA, ASTELLAS
MyLe Hoang, Head of North America and EU Clinical Quality Assurance, EISAI
Daniel Khordi, Executive Director, MRL Quality Assurance, MERCK
Kate Korson, Clinical Trial Participant; Patient Advocate, PENN MEDICINE
Maryann Livolsi, Senior Director, GCP Quality Assurance, BILL AND MELINDA GATES RESEARCH FOUNDATION
Bill McDonald, Quality Business Partner, Data & Digital, R&D Quality & Risk Management, GSK
Olga Rostovtseva, Associate Director, GxP Quality, AMGEN
Abby Statler, PhD, Senior Director, Clinical Quality Assurance, AVEO ONCOLOGY
Ruth Ann Subach, PharmD, BCMAS, Vice President, Clinical Development & Operations, FUJIFILM PHARMACEUTICALS U.S.A., INC.
Melissa Suprin, Head, Risk-Based Quality Management, BEONE MEDICINES
Stefan van den Akker, Head of R&D Quality Risk Management, ACADIA PHARMACEUTICALS
Wil Vickroy, Clinical Research Nurse, UNIVERSITY OF PENNSYLVANIA


The in-person experience is where you’ll gain the most value—through real conversations, shared experiences, and meaningful connection.
In-Person Registration Includes

Join selected live-streamed discussions to engage with speakers, and stay part of the conversation, with the flexibility to revisit key sessions on demand.
Virtual Registration Includes

Connected to 30th Street Station and a parking garage, CYTO | PHL is easy to get to and offers a modern life-science themed Philadelphia event space with many windows and a flexible design, ideal for meaningful engagement.
CYTO | PHL
Cira Centre, 2929 Arch Suite 250,
Philadelphia, PA 19104
In Their Words